Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Asep Medical Holdings Inc C.ASEP

Alternate Symbol(s):  SEPSF

ASEP Medical Holdings Inc. is a Canada-based company, which is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. The Company’s consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. It provides medical devices with an anti-microbial, antifouling coating through its SafeCoat Medical Inc. The Company provides diagnostic kits for predicting the onset of severe Sepsis and organ failure through its Sepset Biosciences Inc. The Company also offers peptide technology through its ABT Innovations Inc. and covers a range of therapeutic applications, including bacterial biofilm infections, anti-inflammatories, anti-infective immune-modulators and vaccine adjuvants. SafeCoat Medical Inc.'s technology incorporates self-assembling biocompatible polymers combined with conjugated antimicrobial peptides.


CSE:ASEP - Post by User

Post by StockHawk1on Jan 17, 2022 4:17pm
183 Views
Post# 34325989

Why hold on to $ASEP

Why hold on to $ASEP

Asep Medical Holdings Inc ( $ASEP.C ) took a huge hit today, closing 14.29% down.


Some reason why it is undervalued IMO: 

-Creating tech to better treat and detect Sepsis which kills 270k in US annually

- Their detection tech beats the industry standard (detecting sepsis 23 hours earlier)

- In global clinical trial phases

- $ASEP plans to apply for regulatory approval in the coming months


IMO it would be unwise to jump ship before the regulatory approval process starts for them as this could be a catalyst. However, this dip does provide an opportunity to get in on the cheap for those who have not yet. 


$ASEP @ $0.60, MC $33.68 M

Shares Outstanding 56.13 M

 
<< Previous
Bullboard Posts
Next >>